Skip to Main Content

Paper Details

Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics.
Eur Urol
68
2020
CDK12, CDK12 gene, CONCLUSIONS CDK12, PARTICIPANTS, PATIENT, Prostate Cancers, cell-cycle pathway gene, patients, prostate cancer, solid cancers, solid tumor, tumor
Author NameAffiliation
Dana E RathkopfMemorial Sloan Kettering Cancer Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
Anuradha GopalanMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Wassim AbidaMemorial Sloan Kettering Cancer Center
  • 1 - 9

Datasets

Release 1.2